COVID19 Vaccination in MS Patients with Immunotherapies – New Data from Israel
A scientific study has just been published in Israel that has investigated the antibody response to the spike protein of SARS-CoV2 in patient groups treated with different MS therapies (Achiron et al. Humoral immune response
Continue reading





